Patent details

Herbas

VPB

Print

EN | LT

LT - CYTIDINE DEAMINASE EXPRESSION LEVEL IN CANCER AS A NEW THERAPEUTIC TARGET

EN - CYTIDINE DEAMINASE EXPRESSION LEVEL IN CANCER AS A NEW THERAPEUTIC TARGET

Legal status

Patent not validated

Bibliographic data

Indications of the International Patent Classification (IPC)
(51)	INT.CL.	C12Q 1/68	(2006.01)
		C12Q 1/6886	(2013.01)

European patent
(11)	Number of the document	3436601
(13)	Kind of document	T
(96)	European patent application number	17715124.8
	Date of filing the European patent application	2017-03-31
(97)	Date of publication of the European application	2019-02-06
(45)	Date of publication and mention of the grant of the patent	2023-03-29
(46)	Date of publication of the claims translation

PCT application
(86)	Number	PCT/EP2017/057752
	Date	2017-03-31

PCT application publication
(87)	Number	WO 2017/167989
	Date	2017-10-05

Priority applications
(30)	Number	Date	Country code
	16305380	2016-03-31	EP

Inventors
(72)	AMOR-GUERET, Mounira , FR MAMERI, Hamza , FR

Grantee
(73)	Centre National de la Recherche Scientifique , 3, rue Michel-Ange, 75016 Paris, FR Institut Curie , 26, rue d'Ulm, 75248 Paris Cedex 05, FR

Title
(54)	CYTIDINE DEAMINASE EXPRESSION LEVEL IN CANCER AS A NEW THERAPEUTIC TARGET
	CYTIDINE DEAMINASE EXPRESSION LEVEL IN CANCER AS A NEW THERAPEUTIC TARGET